FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079136 [Registered on: 21/01/2025] Trial Registered Prospectively
Last Modified On: 20/01/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Unani
Other (Specify) [Hijama bish shart (wet cupping) and compression stockings]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Wet cupping for varicose vein: efficacy and safety 
Scientific Title of Study   Efficacy of Hijama bish shart(wet cupping) in primary varicose vein (Dawali)- A randomized controlled clinical trial 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Budeppa 
Designation  PG Scholar Department of Ilaj bit Tadbeer 
Affiliation  National Institute of Unani Medicine, Bangalore 
Address  OPD No 28, National Institute of Unani Medicine, Kottigepalya, Magadi main road, Bangalore

Bangalore
KARNATAKA
560091
India 
Phone  8147627855  
Fax    
Email  budeppatimmapur8@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Abdul Nasir Ansari 
Designation  Head of Department Department of Ilaj bit Tadbeer 
Affiliation  National Institute of Unani Medicine, Bangalore 
Address  OPD No 28, National Institute of Unani Medicine, Kottigepalya, Magadi main road, Bangalore

Bangalore
KARNATAKA
560091
India 
Phone  9379165162  
Fax    
Email  abdulnasiransari@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Abdul Nasir Ansari 
Designation  Head of Department Department of Ilaj bit Tadbeer 
Affiliation  National Institute of Unani Medicine, Bangalore 
Address  OPD No 28, National Institute of Unani Medicine, Kottigepalya, Magadi main road, Bangalore

Bangalore
KARNATAKA
560091
India 
Phone  9379165162  
Fax    
Email  abdulnasiransari@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Unani Medicine, Kottigepalya, Magadi main road, Bangalore 560091 Karnataka 
 
Primary Sponsor  
Name  National Institute of Unani Medicine 
Address  National Institute of Unani Medicine, Kottigepalya, Magadi main road, Bangalore 560091 Karnataka, India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Budeppa  National Institute of Unani Medicine, Bangalore  OPD 28 Department of Ilaj bit Tadbeer National Institute of Unani Medicine, Kottigepalya, Magadi main road, Bangalore 560091
Bangalore
KARNATAKA 
8147627855

budeppatimmapur8@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Communication of Decision of the Institutional Ethics Committee (IEC) for Biomedical Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I831||Varicose veins of lower extremities with inflammation,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  compression stockings  Control treatment: Compression stockings The elastic compression stocking exerting 20-30 mm Hg of pressure, will be worn daily for 21 days during the daytime (for at least 8 hours) from the ankle to below the knee and removed during the night. 
Intervention  Hijama bish shart (wet cupping) and compression stockings  subjects in the test group will undergo 3 sittings of Hijāma bish Shará¹­ at regular intervals of 7 days (0 day, 7th day and 14th day) and the last assessment for efficacy done on the 21st day. Duration of protocol treatment is 21 days. The wet cupping will be done by following standard operative procedure. One medium-sized (5.2 cm) and one small-sized cup (3 cm) will be applied over the calf region at least 5 cm away from the maximum tortuosity of the most prominent varicose vein. If both calves have varicosities, 2 cups will be applied on each limb. Approximately 10-15 tiny (2mm depth, 2mm length) superficial scarifications will be made at the cupped area and approximately 20 ml of blood will be drawn in medium and 10 ml in small cup and discarded as per NABH guidelines. The values of VCSS will be averaged if varicosities are present in both legs. The vitals of the patients will be recorded before and after the procedure. Compression stockings will be worn by all patients as mentioned in the control group for 21 days.  
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Patient clinically diagnosed case of primary varicose vein
2. willing to sign the informed consent form 
 
ExclusionCriteria 
Details  1.patients having grade 2 hypertension
2.patients of secondary varicose vein
3.pregnant and lactating women
4.patients who fail to follow up
5.patients having diabetus mellitus and other systemic illness eg cancer liver ,kidney, cardiac and pulmonary diseases
6.patients with haemoglobin less than 9.5gm/dl
7.patients having bleeding diathesis,HIV infection, hepatits B and C infection
8. patients of deep venous thrombosis 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
VCSS Score (Revised venous clinical severity score)  At Baseline, 7th day, 14th day, 21st day 
 
Secondary Outcome  
Outcome  TimePoints 
No secondary outcome   Not applicable  
 
Target Sample Size   Total Sample Size="36"
Sample Size from India="36" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   20/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Title of study- Efficacy of Hijama bish shart (wet cupping) in primary varicose vein (Dawali)- A randomized controlled clinical trial

study design-single centre, two armed, parallel groups assessor blinded randomized controlled clinical trial

Intervention- subjects in the test group will undergo 3 sittings of Hijāma bish Shará¹­ at regular intervals of 7 days (0 day, 7th day and 14th day) and the last assessment for efficacy done on the 21st day. The wet cupping will be done by following standard operative procedure. One medium-sized (5.2 cm) and one small-sized cup (3 cm) will be applied over the calf region at least 5 cm away from the maximum tortuosity of the most prominent varicose vein. If both calves have varicosities, 2 cups will be applied on each limb. Approximately 10-15 tiny (2mm depth, 2mm length) superficial scarifications will be made at the cupped area and approximately 20 ml of blood will be drawn in medium and 10 ml in small cup and discarded as per NABH guidelines. The values of VCSS will be averaged if varicosities are present in both legs. The vitals of the patients will be recorded before and after the procedure. Compression stockings will be worn by all patients as mentioned in the control group for 21 days.

control group- Compression stockings The elastic compression stocking exerting 20-30 mm Hg of pressure, will be worn daily for 21 days during the daytime (for at least 8 hours) from the ankle to below the knee and removed during the night.

Primary outcome measure- VCSS Score ( Revised venous clinical severity score)

sample size- 36

site of study- National Institute of Unani Medicine, Bangalore
 
Close